These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28846183)

  • 1. Maximizing donors with viral hepatitis in the current era.
    Brown K
    Liver Transpl; 2017 Oct; 23(S1):S44-S49. PubMed ID: 28846183
    [No Abstract]   [Full Text] [Related]  

  • 2. Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
    Selzner N; Berenguer M
    Liver Transpl; 2018 Jun; 24(6):831-840. PubMed ID: 29624894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use, Safety, and Effectiveness of Viremic Hepatitis B Virus Donor Livers: A Potential Opportunity to Expand the Donor Pool.
    Lee TC; Kaiser TE; Luckett K; Wima K; Winer LK; Morris MC; Kassam AF; Safdar K; Bari K; Anwar N; Quillin RC; Shah SA
    Liver Transpl; 2019 Oct; 25(10):1581-1584. PubMed ID: 31273919
    [No Abstract]   [Full Text] [Related]  

  • 5. An Experiment of Nature: HBV-naive Recipients Receiving Liver Grafts With HBV Core Antibody-positive Donors Without Antiviral Prophylaxis.
    Fallahzadeh MA; Trotter JF
    Transplantation; 2020 Aug; 104(8):e245-e246. PubMed ID: 32732858
    [No Abstract]   [Full Text] [Related]  

  • 6. Pushing the donor limits: Deceased donor liver transplantation using organs from octogenarian donors.
    Díaz Jaime F; Berenguer M
    Liver Transpl; 2017 Oct; 23(S1):S22-S26. PubMed ID: 28779558
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.
    Ting PS; Hamilton JP; Gurakar A; Urrunaga NH; Ma M; Glorioso J; King E; Toman LP; Wesson R; Garonzik-Wang J; Ottmann S; Philosophe B; Sulkowski M; Cameron AM; Durand CM; Chen PH
    Transpl Infect Dis; 2019 Dec; 21(6):e13194. PubMed ID: 31609520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C genotype change after transplantation utilizing hepatitis C positive donor organs.
    Adekunle R; Jonchhe S; Ravichandran B; Wilson E; Husson J
    Transpl Infect Dis; 2018 Aug; 20(4):e12925. PubMed ID: 29797655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Split liver transplantation: Current developments.
    Hackl C; Schmidt KM; Süsal C; Döhler B; Zidek M; Schlitt HJ
    World J Gastroenterol; 2018 Dec; 24(47):5312-5321. PubMed ID: 30598576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients.
    Croome KP; Lee DD; Burns JM; Saucedo-Crespo H; Perry DK; Nguyen JH; Taner CB;
    Liver Transpl; 2016 Aug; 22(8):1099-106. PubMed ID: 27145067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.
    Saberi B; Hamilton JP; Durand CM; Li Z; Philosophe B; Cameron AM; Sulkowski MS; Gurakar A
    Liver Transpl; 2018 Jan; 24(1):140-143. PubMed ID: 28779557
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.
    Mazur RD; Goldberg DS
    Liver Transpl; 2019 Dec; 25(12):1800-1810. PubMed ID: 31539195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
    Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation.
    Crismale JF; Ahmad J
    World J Gastroenterol; 2019 Dec; 25(47):6799-6812. PubMed ID: 31885421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.
    Shaffer AA; Thomas AG; Bowring MG; Van Pilsum Rasmussen SE; Cash A; Kucirka LM; Alqahtani SA; Gurakar A; Sulkowski MS; Cameron AM; Segev DL; Durand CM
    Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Liver Allocation in Eurotransplant.
    Jochmans I; van Rosmalen M; Pirenne J; Samuel U
    Transplantation; 2017 Jul; 101(7):1542-1550. PubMed ID: 28060242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
    Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
    J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation from hepatitis B surface antigen-positive donors.
    Saidi RF; Jabbour N; Shah SA; Li YF; Bozorgzadeh A
    Transplant Proc; 2013; 45(1):279-80. PubMed ID: 23267801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.
    Haugen CE; Thomas AG; Garonzik-Wang J; Massie AB; Segev DL
    Transplantation; 2018 Sep; 102(9):1514-1519. PubMed ID: 29570165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatotic donor livers: Where is the risk-benefit maximized?
    Hamar M; Selzner M
    Liver Transpl; 2017 Oct; 23(S1):S34-S39. PubMed ID: 28734124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.